Home/Filings/4/0001127602-25-013527
4//SEC Filing

Gordon Murdo 4

Accession 0001127602-25-013527

CIK 0000318154other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 8:08 PM ET

Size

6.3 KB

Accession

0001127602-25-013527

Insider Transaction Report

Form 4
Period: 2025-05-02
Gordon Murdo
EVP, Global Commercial Ops
Transactions
  • Tax Payment

    Common Stock

    2025-05-02$283.78/sh740$209,99746,066 total
  • Tax Payment

    Common Stock

    2025-05-02$283.78/sh780$221,34846,806 total
Footnotes (1)
  • [F1]These shares include 442 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001642156

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 8:08 PM ET
Size
6.3 KB